Aziz Sawaf reports a stock award at Vir Biotechnology
By AlphaYouPublished Form 4
Sawaf Aziz
Reporting filer
Aziz Sawaf reports a stock award, not an open-market purchase or sale, in Vir Biotechnology, Inc.. Form 4 filed Nov 16, 2026 lists 2 entries.
- Disclosed
- Nov 16, 2026
Reported details
2 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Sawaf Aziz | 2026-11-15 | A | Grant or award | 75000 | 0 | 75,000 | 1 day | Filed terms
|
| Stock Option (Right to Buy) (derivative) | Sawaf Aziz | 2026-11-15 | A | Grant or award | 150000 | 0 | 150,000 | 1 day | Filed terms
|
Common Stock
- Owner
- Sawaf Aziz
- Date
- 2026-11-15
- Code
- A
- Action
- Grant or award
- Quantity
- 75000
- Price
- 0
- Following holdings
- 75,000
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-15
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- id: F1
- transaction Shares: 75000
- id: F2
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 75000
- direct Or Indirect Ownership: D
Stock Option (Right to Buy) (derivative)
- Owner
- Sawaf Aziz
- Date
- 2026-11-15
- Code
- A
- Action
- Grant or award
- Quantity
- 150000
- Price
- 0
- Following holdings
- 150,000
- Reporting delay
- 1 day
- Filed terms and references
Filed terms
- security Title: Stock Option (Right to Buy)
- conversion Or Exercise Price: 9.96
- transaction Date: 2026-11-15
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 150000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F3
- expiration Date: 2036-11-14
- underlying Security Title: Common Stock
- underlying Security Shares: 150000
- shares Owned Following Transaction: 150000
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Sawaf Aziz: EVP, Chief Financial Officer.
- The filing reports a Rule 10b5-1 trading plan.
- F1: Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan.
- F2: 25% of the RSUs will vest on November 15, 2027, and the remaining RSUs will vest in three equal annual installments thereafter.
- F3: 25% of the shares subject to the stock option will vest and become exercisable on November 15, 2027, and the remaining shares will vest and become exercisable in 36 equal monthly installments thereafter.
Original sources
Prepared automatically from public filing data. Report a correction.